UPDATE -- OXiGENE Announces Positive Topline Results From Randomized Phase 2 Study GOG186I of ZYBRESTAT(R) in Combination With Avastin(R) for Recurrent Ovarian Cancer

Source: Medical News (via PRIMEZONE) - Category: Pharmaceuticals Source Type: news